Indications and uses
For eradication of scabies ( Sarcoptes scabiei ) and for symptomatic treatment of pruritic skin.
Eurax
- Manufacturer
- Journey Medical Corporation | DPT Laboratories, Ltd
- Effective date
- 2025-12-17
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-05-31 22:09:40
Label at a glance#
ProductEurax
Active ingredientCROTAMITON
Label structure11 sections
Dosage and administration
In Scabies: Thoroughly massage into the skin of the whole body from the chin down, paying particular attention to all folds and creases. A second application is advisable 24 hours later. Change clothing and bed linen the next morning. Take a cleansing bath 48 hours after the last application. In Pruritus: Massage gently into affected areas until medication is completely absorbed. Repeat as needed. Take a routine b...
Contacts and useful links#
Websitewww.fda.gov
www.fda.gov/medwatch
www.fda.gov/medwatchWebsitewww.jmcderm.com
www.JMCderm.com
www.JMCderm.comLabel contents#
Full prescribing information#
DESCRIPTION
Eurax (crotamiton, USP) is a scabicidal and antipruritic agent available as a cream for topical use only. Eurax provides 10% (w/w) of the synthetic, crotamiton, USP, in a vanishing-cream base containing: carbomer homopolymer type B, cetyl alcohol, diazolidinyl urea, dimethicone, glyceryl monostearate, laureth-23, magnesium aluminum silicate, benzyl alcohol, petrolatum, propylene glycol, sodium hydroxide, steareth-2, and water. Crotamiton is N-ethyl-N-( o-methylphenyl)-2-butenamide and its structural formula is:
Crotamiton, USP is a colorless to slightly yellowish oil, having a faint amine-like odor. It is soluble with alcohol and with methanol. Crotamiton is a mixture of the cisand transisomers. Its molecular weight is 203.28.
CLINICAL PHARMACOLOGY
Eurax has scabicidal and antipruritic actions. The mechanisms of these actions are not known. The pharmacokinetics of crotamiton and its degree of systemic absorption following topical application have not been determined.
INDICATIONS AND USAGE
For eradication of scabies ( Sarcoptes scabiei) and for symptomatic treatment of pruritic skin.
CONTRAINDICATIONS
Do not apply Eurax topically to patients who develop a sensitivity or are allergic to it or who manifest a primary irritation response to topical medications.
WARNINGS
Discontinue treatment with this product if severe irritation or sensitization develops, and institute appropriate therapy.
PRECAUTIONS
General
Do not apply Eurax in the eyes or mouth because it may cause irritation. Do not apply on acutely inflamed skin or raw or weeping surfaces until the acute inflammation has subsided.
Information for Patients
See DIRECTIONS FOR PATIENTS WITH SCABIES.
Drug Interactions
None known.
Carcinogenesis, Mutagenesis, Impairment of Fertility
Long-term carcinogenicity studies in animals have not been conducted.
Pregnancy
Animal reproduction studies have not been conducted with Eurax. It is also not known whether Eurax can cause fetal harm when applied topically to a pregnant woman or can affect reproduction capacity. Eurax should be given to a pregnant woman only if clearly needed.
Pediatric Use
Safety and effectiveness in pediatric patients have not been established.
Geriatric Use
Clinical studies with Eurax (crotamiton, USP) Cream did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
ADVERSE REACTIONS
Primary irritation reactions, such as dermatitis, pruritus, and rash, and allergic sensitivity reactions have been reported in a few patients.
OVERDOSAGE
There is no specific information on the effect of overtreatment with repeated topical applications in humans.
A death was reported but cause was not confirmed.
Accidental oral ingestion may be accompanied by burning sensation in the mouth, irritation of the buccal, esophageal and gastric mucosa, nausea, vomiting, abdominal pain.
If accidental ingestion occurs, call your Poison Control Center.
DOSAGE AND ADMINISTRATION
In Scabies:Thoroughly massage into the skin of the whole body from the chin down, paying particular attention to all folds and creases. A second application is advisable 24 hours later. Change clothing and bed linen the next morning. Take a cleansing bath 48 hours after the last application.
In Pruritus:Massage gently into affected areas until medication is completely absorbed. Repeat as needed.
DIRECTIONS FOR PATIENTS WITH SCABIES:
- Take a routine bath or shower. Thoroughly massage Eurax cream into the skin from the chin to the toes including folds and creases.
- Put Eurax cream under fingernails after trimming the fingernails short, because scabies are very likely to remain there. A toothbrush can be used to apply the Eurax cream under the fingernails. Immediately after use, wrap the toothbrush in paper and throw it away. Use of the same brush in the mouth could lead to poisoning.
- A second application is advisable 24 hours later.
- A 60 gram tube is sufficient for two applications.
- Change clothing and bed linen the next day. Dry clean contaminated clothing and bed linen, or wash in the hot cycle of the washing machine.
- Take a cleansing bath 48 hours after the last application.
HOW SUPPLIED
Eurax
®(crotamiton, USP) Cream, 10% is a white to yellowish-white soft cream and supplied as:
60 g tube NDC 69489-311-60
Store at room temperature, 20˚C - 25˚C (68˚F - 77˚F); Excursions permitted: 15˚C - 30˚C (59˚F - 86˚F)
[See USP Controlled Room Temperature].
Keep out of reach of children.
To report SUSPECTED ADVERSE REACTIONS, contact Journey Medical Corporation at 1-855-531-1859 or FDA at 1-800-FDA-1088 or
www.fda.gov/medwatch.
Manufactured for:
Journey Medical Corporation
Scottsdale, AZ 85258
www.JMCderm.com
EUR-P01-R00 Revised 12/2025
PACKAGE LABEL PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC 69489-311-60
eurax ®
(crotamiton, USP) Cream (10% w/w)
Rx Only
For topical use only.
Not for ophthalmic, oral,
or intravaginal use.
Net Wt. 60 g
NDC 69489-311-60
eurax ®
(crotamiton, USP) Cream (10% w/w)
Rx Only
For topical use only.
Not for ophthalmic, oral,
or intravaginal use.
Net Wt. 60 g
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 309552 | crotamiton 10 % Topical Cream | PSN | 2 |
| 207864 | Eurax 10 % Topical Cream | PSN | 2 |
| 207864 | crotamiton 100 MG/ML Topical Cream [Eurax] | SBD | 2 |
| 309552 | crotamiton 100 MG/ML Topical Cream | SCD | 2 |
| 309552 | crotamiton 10 % Topical Cream | SY | 2 |
| 207864 | Eurax 10 % Topical Cream | SY | 2 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2ea7942c-f3b4-4c60-49a3-bfc71c3c134e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69489-311-60 | Eurax | 60 g in 1 TUBE | CREAM | 60 | 2 | |
| 69489-311-60 | Eurax | 1 in 1 CARTON | CREAM | 1 | 2 |
Products#
Every source-derived product name is available through these pages.
- Eurax
- crotamiton
- CETYL ALCOHOL
- DIAZOLIDINYL UREA
- CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)
- LAURETH-23
- BENZYL ALCOHOL
- STEARETH-2
- GLYCERYL MONOSTEARATE
- DIMETHICONE
- MAGNESIUM ALUMINUM SILICATE
- PETROLATUM
- PROPYLENE GLYCOL
- SODIUM HYDROXIDE
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 69489-311 | 69489-311-60 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N006927-001 | EURAX | CROTAMITON | 10% | CREAM / TOPICAL | RLD, RS, Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, RS, Approved before 1982 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, RS, Approved before 1982 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, RS, Approved before 1982 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | N006927-001 | EURAX | 10% | CREAM / TOPICAL | RLD, Approved before 1982 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eurax | CROTAMITON | Journey Medical Corporation | 99c826aa-c7dd-4e60-be9c-e9c151033d13 | 2025-12-17 | Warnings, Adverse reactions | 69489-311-60 69489-311 69489031160 4640ba32-cf20-18ad-e063-6394a90a4592 99c826aa-c7dd-4e60-be9c-e9c151033d13 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.